These entirely different manifestations suggest that IGFBP7 functions may be a “double-edged sword” in cancer cell proliferation, progression, and prognosis, displaying an ambiguous action as an oncogene or suppressor gene in distinct types of cancers. This evidence concerns the gene IGFBP7 and cancer.